Status:
RECRUITING
Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase hepatitis C (HCV) treat...
Detailed Description
After an initial ramp-up phase to ensure intervention materials and protocols meet the needs of the target population and organizational setting, we will apply a stratified randomized design to enroll...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Self report injecting drugs in the past month
- Self report a primary injecting partner (currently inject drugs together)
- HCV infection identified at partnering community-based clinical site
Exclusion
Key Trial Info
Start Date :
March 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06179498
Start Date
March 25 2024
End Date
June 1 2027
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94158